Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C5H7NO3 |
| Molecular Weight | 129.114 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1(C)OC(=O)NC1=O
InChI
InChIKey=JYJFNDQBESEHJQ-UHFFFAOYSA-N
InChI=1S/C5H7NO3/c1-5(2)3(7)6-4(8)9-5/h1-2H3,(H,6,7,8)
| Molecular Formula | C5H7NO3 |
| Molecular Weight | 129.114 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Dimethadione (5,5-dimethyl-2,4-oxazolidinedione) is the N-demethylated metabolite of the anticonvulsant trimethadione. Dimethadione is considered to be a blocker of T-type calcium channel. Dimethadione also inhibits a specific potassium channel (Ikr) in HERG-transfected cells. It exerts teratogenic effect especially congenital heart defects. Dimethadione can be used for the measurement of regional tissue pH using positron emission tomography.
CNS Activity
Originator
Sources: http://pubs.acs.org/doi/10.1021/ja01854a019
Curator's Comment: reference retrieved from www.drugfuture.com/chemdata/dimethadione.html
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL240 Sources: https://www.ncbi.nlm.nih.gov/pubmed/12027905 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| In Utero Exposure to a Cardiac Teratogen Causes Reversible Deficits in Postnatal Cardiovascular Function, But Altered Adaptation to the Burden of Pregnancy. | 2015-11 |
|
| Maternal rat serum concentrations of dimethadione do not explain intra-litter differences in the incidence of dimethadione-induced birth defects, including novel findings in foetal lung. | 2014-12-04 |
|
| In utero dimethadione exposure causes postnatal disruption in cardiac structure and function in the rat. | 2014-12 |
|
| Alterations in mouse embryo intracellular pH by DMO during culture impair implantation and fetal growth. | 2010-08 |
|
| Acidic and basic solutions dissolve protein plugs made of lithostathine complicating choledochal cyst/pancreaticobiliary maljunction. | 2009-07 |
|
| Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures. | 2009 |
|
| Glucose loading precipitates focal lactic acidosis in the vulnerable medial thalamus of thiamine-deficient rats. | 2008-03 |
|
| Polytherapy with hERG-blocking antiepileptic drugs: increased risk for embryonic cardiac arrhythmia and teratogenicity. | 2007-08 |
|
| Embryonic cardiac arrhythmia and generation of reactive oxygen species: common teratogenic mechanism for IKr blocking drugs. | 2007-07 |
|
| Pharmacological evidence that stalk cell differentiation involves increases in the intracellular Ca(2+) and H(+) concentrations in Dictyostelium discoideum. | 2007-04 |
|
| Thoracic skeletal defects and cardiac malformations: a common epigenetic link? | 2006-12 |
|
| Interactive effects of cadmium and all-trans-retinoic acid on the induction of forelimb ectrodactyly in C57BL/6 mice. | 2006-01 |
|
| Discriminative power of an assay for automated in vitro screening of teratogens. | 2004-08 |
|
| Disruption of bovine oocytes and preimplantation embryos by urea and acidic pH. | 2003-04 |
|
| Embryonic arrhythmia by inhibition of HERG channels: a common hypoxia-related teratogenic mechanism for antiepileptic drugs? | 2002-05 |
|
| Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests. European Centre for the Validation of Alternative Methods. | 2002-04-25 |
|
| The clinical importance of the trimethadione tolerance test as a method for quantitative assessment of hepatic functional reserve in patients with biliary atresia. | 2001-12 |
|
| Na(+)-dependent pH regulation by the amitochondriate protozoan parasite Giardia intestinalis. | 2001-08-03 |
|
| Altering intracellular pH disrupts development and cellular organization in preimplantation hamster embryos. | 2001-06 |
|
| Trimethadione N-demethylation by rat liver CYP2E1 in vitro. | 1996-07 |
Sample Use Guides
To generate rats with resolved congenital heart defects, pregnant rats were administered distilled water or dimethadione [300 mg/kg b.i.d. on gestation day (gd) 9 and 10] and pups delivered naturally.
In order to detect both pancreatic excretion of dimethadione (DMO), a weak organic acid, and the effect of pancreatic DMO on secretin-stimulated pancreatic secretion, DMO was given intravenously to dogs with pancreatic fistulae at a dose of 50, 100 and 200 mg/kg.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8925801
Unknown
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:51:01 GMT 2025
by
admin
on
Mon Mar 31 17:51:01 GMT 2025
|
| Record UNII |
ALU9NPM703
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
695-53-4
Created by
admin on Mon Mar 31 17:51:01 GMT 2025 , Edited by admin on Mon Mar 31 17:51:01 GMT 2025
|
PRIMARY | |||
|
100000082641
Created by
admin on Mon Mar 31 17:51:01 GMT 2025 , Edited by admin on Mon Mar 31 17:51:01 GMT 2025
|
PRIMARY | |||
|
SUB07170MIG
Created by
admin on Mon Mar 31 17:51:01 GMT 2025 , Edited by admin on Mon Mar 31 17:51:01 GMT 2025
|
PRIMARY | |||
|
DTXSID2020478
Created by
admin on Mon Mar 31 17:51:01 GMT 2025 , Edited by admin on Mon Mar 31 17:51:01 GMT 2025
|
PRIMARY | |||
|
CHEMBL1099
Created by
admin on Mon Mar 31 17:51:01 GMT 2025 , Edited by admin on Mon Mar 31 17:51:01 GMT 2025
|
PRIMARY | |||
|
C171703
Created by
admin on Mon Mar 31 17:51:01 GMT 2025 , Edited by admin on Mon Mar 31 17:51:01 GMT 2025
|
PRIMARY | |||
|
3081
Created by
admin on Mon Mar 31 17:51:01 GMT 2025 , Edited by admin on Mon Mar 31 17:51:01 GMT 2025
|
PRIMARY | |||
|
211-781-4
Created by
admin on Mon Mar 31 17:51:01 GMT 2025 , Edited by admin on Mon Mar 31 17:51:01 GMT 2025
|
PRIMARY | |||
|
D004114
Created by
admin on Mon Mar 31 17:51:01 GMT 2025 , Edited by admin on Mon Mar 31 17:51:01 GMT 2025
|
PRIMARY | |||
|
1130
Created by
admin on Mon Mar 31 17:51:01 GMT 2025 , Edited by admin on Mon Mar 31 17:51:01 GMT 2025
|
PRIMARY | |||
|
m4505
Created by
admin on Mon Mar 31 17:51:01 GMT 2025 , Edited by admin on Mon Mar 31 17:51:01 GMT 2025
|
PRIMARY | Merck Index | ||
|
ALU9NPM703
Created by
admin on Mon Mar 31 17:51:01 GMT 2025 , Edited by admin on Mon Mar 31 17:51:01 GMT 2025
|
PRIMARY | |||
|
30152
Created by
admin on Mon Mar 31 17:51:01 GMT 2025 , Edited by admin on Mon Mar 31 17:51:01 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
BINDER->LIGAND |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE ACTIVE | |||
|
PARENT -> METABOLITE TOXIC |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |